Intracameral sodium hyaluronate for postoperative hypotony after Baerveldt glaucoma implant
1 June 2019
| Ivan Yip
|
EYE - Glaucoma
This is a retrospective study to examine the effect of 0.1ml of sodium intracameral sodium hyaluronate 1.4% (Healon GV – HGV) in patients who had hypotony (IOP<5mmHg) within three months of having a Baerveldt glaucoma implant (BGI) operation. Hypotony is...
Improving reading of fundus photographs in an emergency setting
1 June 2019
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Fundus photography, telemedicine, training
The first phases of the FOTO-ED study found that emergency providers perform significantly better with fundus photography than with direct ophthalmoscopy in the detection of fundus abnormalities. The authors hypothesised that by providing additional training to emergency providers, this would...
A case report showing the natural history of papilloedema
1 June 2019
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Optic cup, intracranial hypertension, papilloedema
The case report describes a 54-year-old woman who developed increased intracranial hypertension due to chronic dural venous sinus thrombosis in the absence of any significant comorbidity. In the years preceding diagnosis, the patient underwent routine diabetic retinopathy screening; however, gradual...
Corneal neurotisation with an allograft
1 June 2019
| James Hsuan
|
EYE - Oculoplastic
This is the first reported use of an acellular nerve allograft for corneal neurotisation. Seven patients received a 7cm long commercially prepared acellular nerve allograft. This was coapted to a functioning supratrochlear, supraorbital or infraorbital nerve and then tunnelled to...
IgG4-related disease or Graves orbitopathy
1 June 2019
| James Hsuan
|
EYE - Oculoplastic
This is retrospective review of patients who had been diagnosed with both IgG4-related ophthalmic disease (IgG4-ROD) and Graves orbitopathy over a four year period. Eight patients were identified. The diagnosis of IgG4-ROD was based on 10 or more IgG4+ plasma...
AC/A measurement differences
The authors sought to investigate differences in stimulus accommodative convergence/accommodation (AC/A) ratio using various techniques and accommodative stimuli. The study included 81 orthoptic students; 15 males and 66 females with a mean age of 21 years ±1. Ocular deviation was...
IINS function
This study explored the impact of idiopathic infantile nystagmus syndrome (IINS) on quality of life in adults measured using the VFQ25 questionnaire. Of 38 subjects, 35 completed the questionnaire. Mean age was 35.1±13.0 years; 15 were British Caucasian and 14...
BT for convergence spasm
The aim of this study was to analyse the response of a cohort of patients with convergence spasm to the injection of botulinum toxin (BT) in the medial rectus muscle. This was a retrospective study of six patients with a...
DRIL after macular oedema treatment in BRVO
1 June 2019
| Sofia Rokerya
|
EYE - Vitreo-Retinal
The authors report the analysis of a single-site, retrospective, cross-sectional study to evaluate the association between disorganisation of the retinal inner layers (DRIL) and visual acuity (VA) after anti-VEGF treatment for macular oedema (MO) due to branch retinal vein occlusion...
Vitrectomy in retinal detachment associated with choroidal detachment
1 June 2019
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
Hypotony, posterior retinal breaks, longer axial lengths and total retinal detachments (RD) are risk factors for development of RD associated with choroidal detachment (RRDCD). This study retrospectively analysed the anatomic outcomes and prognostic factors of vitrectomy in 175 patients with...
Diclofenac versus Bromfenac after cataract surgery
1 April 2019
| Kurt Spiteri Cornish
|
EYE - Cataract, EYE - Refractive
|
Non-steroidal anti-inflammatory drugs, bromfenac, cataract surgery, diclofenac, intraocular inflammation
Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used after cataract surgery to reduce inflammation and cystoid macular oedema (CMO). Diclofenac 0.1% is used three to five times daily for 28 days and Bromfenac 0.09% twice daily for 14 days postoperatively. The...
Temporal versus nasal clear corneal incisions
1 April 2019
| Jonathan Chan
|
EYE - Cataract, EYE - Refractive
|
cataract surgery, corneal shape change, nasal clear corneal incision, temporal clear corneal incision
This is a prospective randomised study of 100 patients’ left eye having undergone phacoemulsification either by a 2.4mm nasal clear corneal incision (CCI) group or temporal CCI group. The corneal astigmatic changes were compared between groups by power vector analysis,...
